NRD
DXCM icon

Nebula Research & Development’s DexCom DXCM Stock Holding History

Nebula Research & Development’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,977
Closed -$434K – 279
2025
Q2 		$434K Sell
4,977
-15,324
-75% -$1.2M 0.04% 676
2025
Q1 		$1.39M Buy
+20,301
New +$1.66M 0.13% 265
2024
Q3 		– Sell
-17,094
Closed -$1.94M – 988
2024
Q2 		$1.94M Buy
+17,094
New +$2.16M 0.31% 65
2023
Q4 		– Sell
-6,340
Closed -$592K – 699
2023
Q3 		$592K Buy
+6,340
New +$715K 0.31% 93

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nebula Research & Development's DXCM Position: Q3 2025 in Review

Nebula Research & Development sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,977 shares — an estimated $434K sold.

Nebula Research & Development first reported a position in DXCM in Q3 2023 and held it in 4 quarters. The position peaked at $1.94M in Q2 2024. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Nebula Research & Development reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 4,977 DexCom shares in Q3 2025, an estimated $434K.
  • Nebula Research & Development first reported a position in DexCom in Q3 2023 and held it in 4 quarters.
  • Nebula Research & Development's DexCom position peaked at $1.94M in Q2 2024.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.